Journal of the American Academy of Dermatology
Volume 63, Issue 5 , Pages 815-823, November 2010

Role of primary prophylaxis for pneumocystis pneumonia in patients treated with systemic corticosteroids or other immunosuppressive agents for immune-mediated dermatologic conditions

  • Julia S. Lehman, MD
    • ,
  • Amer N. Kalaaji, MD

      Affiliations

    • Corresponding Author InformationReprint requests: Amer N. Kalaaji, MD, Department of Dermatology, Mayo Clinic, 200 First St SW, Rochester, MN 55905.

Department of Dermatology, Mayo Clinic, Rochester, Minnesota

Accepted 22 November 2009. published online 20 July 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Funding sources: None.

 Conflicts of interest: None declared.

PII: S0190-9622(09)02112-4

doi:10.1016/j.jaad.2009.11.588

Journal of the American Academy of Dermatology
Volume 63, Issue 5 , Pages 815-823, November 2010

Article Tools